ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CYRX vs ORIC // FREE CASH FLOW YIELD

CryoPort Inc. (NASDAQ) VS. Oric Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: CYRX 4 — ORIC 1
▲ FREE CASH FLOW YIELD LEADER: CYRX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CYRX VS. ORIC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CYRX ORIC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 47.10% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -11.50% -33.40% +21.90 CYRX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -2.70% -11.99% +9.29 CYRX /fcf-yield <GO>
Operating Margin -20.90% — — TIE /operating-margins <GO>
Net Profit Margin 44.40% — — TIE /net-margins <GO>
Revenue Growth (YoY) 12.40% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.33 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 2/9 +3.00 CYRX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.6 31.8 +24.80 CYRX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 9.9x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $926.4M $931.8M -$5.5M ORIC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CYRX REV ORIC REV CYRX GROSS % ORIC GROSS % CYRX FCF ORIC FCF
FY 2025 $176.2M $0 47.1% — -$25.0M -$111.7M
FY 2024 $156.8M $0 44.4% — -$33.6M -$113.8M
FY 2023 $168.7M $0 — — -$757.0K -$85.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CYRX // BETA —
ORIC // BETA —